Breast Biopsy Devices Market to receive overwhelming hike in revenues by 2016-2022- Credence Research

The latest industry report published by Credence Research “Global Breast Biopsy Devices industry - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022,” the breast biopsy devices industry was valued at USD 617.62 Mn in 2015, and is expected to reach USD 1,250.71 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.
Browse the full report Breast Biopsy Devices industry - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at http://www.credenceresearch.com/report/breast-biopsy-devices-market
Industry Insights
Breast cancer is among the most commonly diagnosed non-skin cancer across the world, with among the highest annual mortality. While the incidence of the disease is increasing at alarming rates in the developing industrys, the breast cancer survival prognosis is reported to be con tenuously improving this proving development in the trends of early disease diagnosis and treatment outcomes. Pathological detection of breast cancer has evolved a long way until present with biopsy becoming the standard route of disease detection. With the introduction of minimally invasive biopsy procedures, intimating with fine needle aspiration, the global breast biopsy devices industry has witnessed phenomenal growth over the period. Rapidly aging population and the proven correlation of age with the incidence of breast cancer is among the biggest contributors to the breast biopsy devices industry. Alarming disease incidence and technological development resulting in rapid adoption of breast biopsy devices and related solutions are observed to be the major industry drivers in the developing regions of the world. Introduction of guidance enabled biopsy systems has further facilitated the industry development and assisted in containment of breast cancer incidence.
Industry Competition Assessment
Te global breast biopsy devices industry is consolidated with a few players dominating the major chunk of the industry revenue. Players such as Hologic, Mammotome, C.R. Bar, Inc. are identified and recognized as the global industry leaders. Other players such as Argon Medical Devices, Becton Dickinson and Company, Sterylab are the promising industry players with their established positions in prime industry segments.
Key industry Movements
• Increased preference for minimally invasive biopsies
• Rapid shift towards guided biopsies
• Growth in adoption of disposable consumables
Browse the full report Breast Biopsy Devices industry - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at http://www.credenceresearch.com/report/breast-biopsy-devices-market
ToC:
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Breast Biopsy Devices Market, by Biopsy Type, 2015 (USD Mn)
2.2 Breast Biopsy Devices Market Share, by Product Type, 2015 & 2022 (Value %)
2.3 Breast Biopsy Devices Market, by Guidance Type, 2015 (USD Mn)
2.4 Breast Biopsy Devices Market Share, by Geography, 2015 (Value %)
Chapter 3 Breast Biopsy Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.1.1 Breast Cancer Estimated Incidence & Mortality, Worldwide (2012)
3.2 Drivers
3.2.1 Population Aging Contributing to Mandate for Cancer Diagnostics
3.2.1.1 Age-specific Breast Cancer Rates: United States
3.2.1.2 Age Statistics Above 65, by Key Countries, 2015 - 2030
3.2.2 Excessive Disease Prevalence
3.2.2.1 Estimated Incidence, Mortality and Prevalence of Breast Cancer, Worldwide, 2012
3.3 Challenges
3.3.1 High Costs of Biopsy May Constrain Growth
3.3.2 Susceptibility to Radiation Exposure….

Blog:
• http://www.healthwant.com/
• http://www.techtopworld.com/
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com

About Us:
Credence Research is a worldwide Market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290

This release was published on openPR.